QIMR Berghofer Medical Research Institute:製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】QIMR Berghofer Medical Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C9331)・商品コード:DATA904C9331
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:42
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥52,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥78,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
QIMR Berghofer Medical Research Institute (QIMR), formerly Queensland Institute of Medical Research is a medical research institute that offers education and research programs. The institute offers its research programs in the areas of mental health, cancer, infectious disease, and complex disorders. Its cancer research areas includes breast cancer, blood cancer, brain cancer, lung cancer, endometrial cancer, melanoma, nasopharyngeal carcinoma, pancreatic cancer, prostate cancer, ovarian cancer, and stomach cancer, among others. QIMR offers services such as project development, management, budgeting and research contracts, and intellectual property identification, protection and commercialisation services. The institute also provides technology transfers, clinical trials, and contract research and development services. QIMR is headquartered in Brisbane, Queensland, Australia.

QIMR Berghofer Medical Research Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
QIMR Berghofer Medical Research Institute, Medical Devices Deals, 2012 to YTD 2018 9
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Invenra Enters into Agreement with QIMR Berghofer Medical Research Institute 11
Licensing Agreements 12
Atara Biotherapeutics Amends Licensing Agreement with QIMR Berghofer 12
Bristol-Myers Squibb Enters into Licensing Agreement with QIMR Berghofer Medical Research Institute 13
QIMR Berghofer Medical Research Institute – Key Competitors 14
QIMR Berghofer Medical Research Institute – Key Employees 15
QIMR Berghofer Medical Research Institute – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Strategy And Business Planning 17
Jul 04, 2018: Leading clinical trials company expands for the future 17
Nov 29, 2017: ACRF grant to transform Queensland into global immunotherapy hub 18
Government and Public Interest 19
Jun 25, 2018: Major Study Uncovers New Breast Cancer Genes And Opens The Door For More Discoveries 19
May 10, 2018: Researchers uncover how infant viral infections become childhood asthma 20
May 09, 2018: Global genetic study of skin colour unearths 14 new genetic markers 22
Apr 16, 2018: New biomarker for prostate cancer could help guide treatment pathways 23
Mar 27, 2018: Australian vaccine innovation set to strike out zika and chikungunya in one go 25
Mar 16, 2018: Scientists identify new possibility for untreatable blood cancer 27
Feb 13, 2018: Researchers build tiny DNA nanorobots to block cancer growth 29
Jan 02, 2018: Scientists solve puzzle of why some children with cystic fibrosis sustain liver damage 31
Nov 29, 2017: Australian Cancer Research Foundation Awards $7.5 Million To Accelerate Cancer Research Across Australia 33
Nov 13, 2017: Research uncovers potential new approach for treating asthma 34
Aug 08, 2017: Researchers Identify Two New Breast Cancer Genes 35
Jul 20, 2017: Gene Discovery to Help Breast Cancer Patients 36
Product News 37
Jul 06, 2018: Hope for transplant patients after world-first Queensland immunotherapy trial 37
Jul 02, 2018: Queensland researchers design clinical trial model that could eradicate malaria 38
Other Significant Developments 40
Jul 30, 2018: Researchers identify 40 new genetic markers for glaucoma 40
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Key Facts 2
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QIMR Berghofer Medical Research Institute, Deals By Therapy Area, 2012 to YTD 2018 8
QIMR Berghofer Medical Research Institute, Medical Devices Deals, 2012 to YTD 2018 9
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Invenra Enters into Agreement with QIMR Berghofer Medical Research Institute 11
Atara Biotherapeutics Amends Licensing Agreement with QIMR Berghofer 12
Bristol-Myers Squibb Enters into Licensing Agreement with QIMR Berghofer Medical Research Institute 13
QIMR Berghofer Medical Research Institute, Key Competitors 14
QIMR Berghofer Medical Research Institute, Key Employees 15
QIMR Berghofer Medical Research Institute, Other Locations 16
QIMR Berghofer Medical Research Institute, Subsidiaries 16

List of Figures
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
QIMR Berghofer Medical Research Institute, Medical Devices Deals, 2012 to YTD 2018 9

★調査レポート[QIMR Berghofer Medical Research Institute:製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C9331)販売に関する免責事項を必ずご確認ください。
★調査レポート[QIMR Berghofer Medical Research Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆